Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-17-056197
Filing Date
2017-09-08
Accepted
2017-09-08 06:00:46
Documents
6
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A a17-21498_110ka.htm 10-K/A 39620
2 EX-10.1 a17-21498_1ex10d1.htm EX-10.1 700834
3 EX-31.1 a17-21498_1ex31d1.htm EX-31.1 11578
4 EX-31.2 a17-21498_1ex31d2.htm EX-31.2 11583
5 GRAPHIC g214981kk19i001.jpg GRAPHIC 3460
6 GRAPHIC g214981kk19i002.jpg GRAPHIC 5423
  Complete submission text file 0001104659-17-056197.txt   777122
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-16633 | Film No.: 171075039
SIC: 2834 Pharmaceutical Preparations